Structural Determinants of p53-Independence in Anticancer Ruthenium-Arene Schiff-Base Complexes

Abstract excerpt

p53 is a key tumor suppressor gene involved in key cellular processes and implicated in cancer therapy. However, it is inactivated in more than 50% of all cancers due to mutation or overexpression of its negative regulators. This leads to drug resistance and poor chemotherapeutic outcome as most clinical drugs act via a p53-dependent mechanism of action. An attractive strategy to circumvent this resistance would...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Metal complexes synthesis and properties